Avanos Medical's 15-minute chart shows Bollinger Bands Expanding Downward, KDJ Death Cross.
ByAinvest
Wednesday, Aug 13, 2025 2:48 pm ET1min read
AVNS--
Technical Indicators Analysis
Bollinger Bands, a volatility indicator, consist of a simple moving average and two standard deviations above and below it. When the bands expand, it indicates increased volatility and potential price movements in the direction of the expansion. In Avanos Medical's case, the expanding Bollinger Bands suggest heightened volatility and a potential downward trend in the stock price.
The KDJ Death Cross, derived from the KDJ indicator, signals a bearish trend when the K line crosses below the D line. The occurrence of this cross on Avanos Medical's 15-minute chart on August 13, 2025, further supports the notion of a downward trend.
Market Reactions and Implications
Despite the recent technical signals, it is essential to consider Avanos Medical's financial performance. In the second quarter of 2025, the company reported a 50% year-over-year decline in adjusted earnings per share (EPS) and a GAAP loss per share of $1.66. However, revenues grew by 1.9% year over year, driven by strong demand in the Specialty Nutrition Systems (SNS) portfolio and positive momentum in radiofrequency ablation (RFA) generator sales [1].
Avanos Medical continues to face challenges, including a volatile tariff environment and the divestiture of its Hyaluronic Acid (HA) product line. The company has implemented a multi-pronged strategy to mitigate the impact of tariffs, including internal cost containment, pricing actions, and lobbying efforts.
Investment Considerations
While the recent technical indicators suggest a potential downward trend, investors should carefully consider Avanos Medical's broader financial performance and the broader market conditions before making investment decisions. The expanding Bollinger Bands and KDJ Death Cross provide a signal that the stock price may continue to decline, but the company's efforts to navigate through challenges may also influence its stock performance.
Conclusion
Avanos Medical's 15-minute chart indicates a significant downward trend, as evidenced by the expanding Bollinger Bands and the KDJ Death Cross on August 13, 2025, at 14:45. These technical indicators suggest a shift in market momentum towards the downside, potentially signaling further price decreases. However, investors should consider the company's financial performance and broader market conditions when making investment decisions.
References:
[1] https://www.tradingview.com/news/zacks:9982d36bf094b:0-avanos-medical-stock-down-as-q2-earnings-miss-estimates-margins-down/
[2] https://finance.yahoo.com/news/avanos-medical-stock-down-q2-170800471.html
Avanos Medical's 15-minute chart displays a significant downward trend, as evidenced by the expanding Bollinger Bands and the KDJ Death Cross occurring on August 13, 2025, at 14:45. This suggests that the market momentum is shifting towards the downside, with a potential for further price decreases.
Avanos Medical's 15-minute chart has recently displayed a significant downward trend, as evidenced by the expanding Bollinger Bands and the KDJ Death Cross occurring on August 13, 2025, at 14:45. These technical indicators suggest a shift in market momentum towards the downside, potentially signaling further price decreases.Technical Indicators Analysis
Bollinger Bands, a volatility indicator, consist of a simple moving average and two standard deviations above and below it. When the bands expand, it indicates increased volatility and potential price movements in the direction of the expansion. In Avanos Medical's case, the expanding Bollinger Bands suggest heightened volatility and a potential downward trend in the stock price.
The KDJ Death Cross, derived from the KDJ indicator, signals a bearish trend when the K line crosses below the D line. The occurrence of this cross on Avanos Medical's 15-minute chart on August 13, 2025, further supports the notion of a downward trend.
Market Reactions and Implications
Despite the recent technical signals, it is essential to consider Avanos Medical's financial performance. In the second quarter of 2025, the company reported a 50% year-over-year decline in adjusted earnings per share (EPS) and a GAAP loss per share of $1.66. However, revenues grew by 1.9% year over year, driven by strong demand in the Specialty Nutrition Systems (SNS) portfolio and positive momentum in radiofrequency ablation (RFA) generator sales [1].
Avanos Medical continues to face challenges, including a volatile tariff environment and the divestiture of its Hyaluronic Acid (HA) product line. The company has implemented a multi-pronged strategy to mitigate the impact of tariffs, including internal cost containment, pricing actions, and lobbying efforts.
Investment Considerations
While the recent technical indicators suggest a potential downward trend, investors should carefully consider Avanos Medical's broader financial performance and the broader market conditions before making investment decisions. The expanding Bollinger Bands and KDJ Death Cross provide a signal that the stock price may continue to decline, but the company's efforts to navigate through challenges may also influence its stock performance.
Conclusion
Avanos Medical's 15-minute chart indicates a significant downward trend, as evidenced by the expanding Bollinger Bands and the KDJ Death Cross on August 13, 2025, at 14:45. These technical indicators suggest a shift in market momentum towards the downside, potentially signaling further price decreases. However, investors should consider the company's financial performance and broader market conditions when making investment decisions.
References:
[1] https://www.tradingview.com/news/zacks:9982d36bf094b:0-avanos-medical-stock-down-as-q2-earnings-miss-estimates-margins-down/
[2] https://finance.yahoo.com/news/avanos-medical-stock-down-q2-170800471.html
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet